馬用ヘルスケア市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

馬用ヘルスケア市場の2023年の市場規模は32億5,000万米ドルで、2024年には34億6,000万米ドルに達すると予測され、CAGR 6.52％で成長し、2030年には50億7,000万米ドルに達すると予測されています。

馬用ヘルスケア市場は、治療、獣医学的ケア、栄養補助食品、医薬品など、さまざまなサービスや製品を通じて馬の健康と幸福を維持することに焦点を当てた幅広い範囲を網羅しています。馬用ヘルスケアの必要性は、馬がスポーツ、レジャー、農業、交友関係において提供する経済的および感傷的な価値に起因しており、最適な健康とパフォーマンス維持の必要性を強調しています。この市場は、疾病予防、傷害治療、繁殖健康、診断、カスタマイズされた栄養計画などに応用されています。最終用途には、動物診療所、牧場、競走馬調教師、繁殖センターなどが含まれます。市場成長は、世界の馬人口の増加、獣医学における技術の進歩、馬術スポーツの人気上昇、動物福祉に関する飼い主の意識向上などの影響を受けています。この市場では、遠隔医療やウェアラブル技術のようなデジタルヘルスソリューションによって、リアルタイムの健康モニタリングやデータ分析を提供する機会が急増しています。これらを捉えるために、利害関係者は診断ツールや個別化された治療計画の革新のためにIoTやAI技術の統合に投資しなければならないです。しかし、高度な治療にかかる高額な費用、熟練した獣医師の不足、さまざまな規制、発展途上地域における経済的制約といった課題が大きな障壁となっています。また、他の畜産分野に比べて市場シェアが相対的に小さいことにも限界があります。企業は、遺伝性疾患の予防、傷害に対する幹細胞治療、より良い結果が期待できる代替医薬品などの研究分野に注力すべきです。また、手頃な価格の動物用遠隔医療ソリューションを開発するためのハイテク企業とのコラボレーションも成長を促進する可能性があります。全体として、馬用ヘルスケア市場は、ペットのヒューマニゼーションとスポーツへの投資の高まりに牽引されて進化しているが、コストとアクセシビリティの問題が足かせとなっています。戦略的パートナーシップ、手頃な価格のケアソリューションの継続的な革新、新興市場での的を絞った働きかけが、この分野の大幅な成長と進歩の触媒として機能する可能性があります。

市場力学：急速に進化する馬用ヘルスケア市場の主要市場インサイトを公開

馬用ヘルスケア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 馬術スポーツの人気の高まりと、レジャーや交友のための馬所有の増加
  • 動物の健康と福祉に対する意識の高まり
  • 馬用ヘルスケアに対する政府や公的機関による財政支援
• 市場抑制要因
  • 獣医療サービスと高度な治療にかかる費用の高騰
• 市場機会
  • 馬の病気の診断・治療法の技術的進歩
  • 環境に優しく持続可能なヘルスケア製品への需要の高まり
• 市場の課題
  • 副作用や耐性菌のリスク

ポーターのファイブフォース：馬用ヘルスケア市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：馬用ヘルスケア市場における外部からの影響の把握

外部マクロ環境要因は、馬用ヘルスケア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析馬用ヘルスケア市場における競合情勢の把握

馬用ヘルスケア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス馬用ヘルスケア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、馬用ヘルスケア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨馬用ヘルスケア市場における成功への道筋を描く

馬用ヘルスケア市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 馬術スポーツの人気の高まりと、娯楽や交友関係での馬の所有の増加
    • 動物の健康と福祉に関する意識の高まり
    • 馬用ヘルスケアに対する政府および公的機関による財政支援
  • 抑制要因
    • 獣医サービスと高度な治療の高額な費用
  • 機会
    • 馬の病気の診断と治療法の技術的進歩
    • 環境に優しく持続可能なヘルスケア製品に対する需要の増加
  • 課題
    • 薬物有害反応および耐性のリスク
• 市場セグメンテーション分析
  • 製品：馬の病気の検出と管理のための診断ツールの広範な使用
  • 応用：診断、モニタリング、治療における馬用ヘルスケアの採用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 馬用ヘルスケア市場：製品別

• 診断ツール
• 飼料サプリメント
  • 関節サプリメント
  • ビタミンとミネラル
• 医薬品
  • 鎮痛剤
  • 抗炎症薬
  • 抗生物質
  • 駆虫薬
  • 鎮静剤
• ワクチン

第7章 馬用ヘルスケア市場：用途別

• 診断、モニタリング、治療
• 外科的応用

第8章 馬用ヘルスケア市場：エンドユーザー別

• 獣医クリニックと病院
• 獣医学研究所
• 獣医調査機関

第9章 南北アメリカの馬用ヘルスケア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の馬用ヘルスケア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの馬用ヘルスケア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ネオジェン、テラノバとのバイオセキュリティ提携を発表
  • ヒルトップバイオが馬の関節用Strydaflexを発売
  • コヴェトラス、馬の強力な免疫防御をサポートするスマートイミューンキノコを発売
• 戦略分析と提言

企業一覧

• Alltech Inc.
• Archer-Daniels-Midland Company
• Bayer AG
• Belvoir Equine Limited
• Boehringer Ingelheim International GmbH
• Cargill, Incorporated
• Ceva Sante Animale
• Covetrus, Inc.
• Dechra Pharmaceuticals PLC
• ELANCO ANIMAL HEALTH INCORPORATED
• ESAOTE SPA
• Hallmarq Veterinary Imaging Inc.
• Hilltop Biosciences
• IDEXX Laboratories, Inc.
• Kent Nutrition Group
• Land O'Lakes, Inc.
• Merck & Co., Inc.
• Mg Biologics
• Neogen Corporation
• Platinum Performance, Inc.
• Sanofi S.A.
• Vetoquinol S.A.
• W.F. Young, Inc.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. EQUINE HEALTHCARE MARKET RESEARCH PROCESS
• FIGURE 2. EQUINE HEALTHCARE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EQUINE HEALTHCARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EQUINE HEALTHCARE MARKET DYNAMICS
• TABLE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSTICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SEDATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSIS, MONITORING & THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SURGICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 46. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 73. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 78. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 164. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 184. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 189. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

The Equine Healthcare Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.46 billion in 2024, and is projected to grow at a CAGR of 6.52%, to USD 5.07 billion by 2030.

The equine healthcare market encompasses a broad scope focused on maintaining the health and well-being of horses through various services and products, including medical treatments, veterinary care, nutritional supplements, and pharmaceuticals. The necessity for equine healthcare stems from the economic and sentimental value horses provide in sports, leisure, agriculture, and companionship, emphasizing a need for optimal health and performance maintenance. This market finds applications in disease prevention, injury treatment, reproductive health, diagnostics, and customized nutrition plans. End-use scope includes animal clinics, horse farms, racehorse trainers, and breeding centers. Market growth is influenced by an increasing global equine population, technological advancements in veterinary medicine, a rise in equestrian sports popularity, and enhanced owner awareness about animal welfare. Opportunities in this market are burgeoning with digital health solutions like telemedicine and wearable tech, offering real-time health monitoring and data analytics. To seize these, stakeholders must invest in integrating IoT and AI technologies for innovations in diagnostic tools and personalized treatment plans. However, challenges such as high costs of advanced treatments, lack of skilled veterinarians, varying regulations, and economic constraints in developing regions pose significant barriers. Limitations also arise from the relatively small market share compared to other livestock sectors. Businesses should focus on research areas like genetic disease prevention, stem cell therapy for injuries, and alternative medicines that promise better outcomes. Collaborations with tech companies for developing affordable veterinary telehealth solutions could also drive growth. Overall, the equine healthcare market is evolving, driven by rising pet humanization and sports investments, yet hampered by cost and accessibility issues. Strategic partnerships, continued innovation in affordable care solutions, and targeted outreach in emerging markets can serve as a catalyst for substantial growth and advancement in this field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Healthcare Market

The Equine Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing popularity of equine sports and increased horse ownership for leisure and companionship
  • Heightened awareness regarding animal health and welfare
  • Financial support offered by government and public organizations for equine healthcare
• Market Restraints
  • High cost of veterinary services and advanced treatments
• Market Opportunities
  • Technological advancements in diagnostic and treatment methods for equine diseases
  • Increasing demand for eco-friendly and sustainable healthcare products
• Market Challenges
  • Risk of adverse drug reactions and resistance

Porter's Five Forces: A Strategic Tool for Navigating the Equine Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Healthcare Market

A detailed market share analysis in the Equine Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Healthcare Market

A strategic analysis of the Equine Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diagnostics tools, Feed Supplements, Pharmaceuticals, and Vaccines. The Feed Supplements is further studied across Joint Supplements and Vitamins & Minerals. The Pharmaceuticals is further studied across Analgesics, Anti-inflammatory Drugs, Antibiotics, Antiparasitics, and Sedatives.
• Based on Application, market is studied across Diagnosis, Monitoring & Therapy and Surgical Application.
• Based on End-User, market is studied across Veterinary Clinics & Hospitals, Veterinary Laboratories, and Veterinary Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing popularity of equine sports and increased horse ownership for leisure and companionship
    • 5.1.1.2. Heightened awareness regarding animal health and welfare
    • 5.1.1.3. Financial support offered by government and public organizations for equine healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary services and advanced treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in diagnostic and treatment methods for equine diseases
    • 5.1.3.2. Increasing demand for eco-friendly and sustainable healthcare products
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of adverse drug reactions and resistance
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Extensive use of diagnostics tools for the detection and management of equine diseases
  • 5.2.2. Application: Increasing adoption of equine healthcare in diagnosis, monitoring & therapy
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Equine Healthcare Market, by Product

• 6.1. Introduction
• 6.2. Diagnostics tools
• 6.3. Feed Supplements
  • 6.3.1. Joint Supplements
  • 6.3.2. Vitamins & Minerals
• 6.4. Pharmaceuticals
  • 6.4.1. Analgesics
  • 6.4.2. Anti-inflammatory Drugs
  • 6.4.3. Antibiotics
  • 6.4.4. Antiparasitics
  • 6.4.5. Sedatives
• 6.5. Vaccines

7. Equine Healthcare Market, by Application

• 7.1. Introduction
• 7.2. Diagnosis, Monitoring & Therapy
• 7.3. Surgical Application

8. Equine Healthcare Market, by End-User

• 8.1. Introduction
• 8.2. Veterinary Clinics & Hospitals
• 8.3. Veterinary Laboratories
• 8.4. Veterinary Research Institutes

9. Americas Equine Healthcare Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Equine Healthcare Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Equine Healthcare Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Neogen Announced Biosecurity Partnership with TerraNova
  • 12.3.2. Hilltop Bio Launched Strydaflex for Equine Joints
  • 12.3.3. Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alltech Inc.
• 2. Archer-Daniels-Midland Company
• 3. Bayer AG
• 4. Belvoir Equine Limited
• 5. Boehringer Ingelheim International GmbH
• 6. Cargill, Incorporated
• 7. Ceva Sante Animale
• 8. Covetrus, Inc.
• 9. Dechra Pharmaceuticals PLC
• 10. ELANCO ANIMAL HEALTH INCORPORATED
• 11. ESAOTE SPA
• 12. Hallmarq Veterinary Imaging Inc.
• 13. Hilltop Biosciences
• 14. IDEXX Laboratories, Inc.
• 15. Kent Nutrition Group
• 16. Land O'Lakes, Inc.
• 17. Merck & Co., Inc.
• 18. Mg Biologics
• 19. Neogen Corporation
• 20. Platinum Performance, Inc.
• 21. Sanofi S.A.
• 22. Vetoquinol S.A.
• 23. W.F. Young, Inc.
• 24. Zoetis Inc.